Sounds absolutely amazing!

No, that one doesn’t

I grew up in London and to me, yes it does

And the possibility of making drafts!

🤍

I spend a lot of time on each review, reading the paper multiple times, trying to help the author find the best way to present their ideas, but I'm not sure I would do that to the same extent if I was asked by a reviewer whether to accept or reject. Maybe I should though... the problem could be me!

Yes, I hear you. The fact that reviewers can be very critical is what makes their reports so valuable in a way, they make it possible to actually address errors and weaknesses. Which is why I don’t love the idea of doing away with R&Rs

People say that peer-review doesn’t exist to improve papers and that should be the role of colleagues and presentation attendees. I see where that’s coming from but in my experience, reviewers (perhaps because they’re anonymous) tend to be much more critical and that’s profoundly helpful

As an author, I don’t really mind starting a new submission elsewhere vs resubmitting a revised version, but I really want to read the report! And what I’m worried about under the Ergo model is that reports become very short and not as helpful to the author

I’m the same, I always see something good in a paper and want it to be expanded on, but I think editors don’t like that too much :/

I’m inclined to say the opposite. Now people can give R&Rs when a paper is more out there, encouraging the author to make things perhaps clearer to the conservative. Under that proposal would they not just recommend rejection?

Would you not have wanted to disagree, or point out errors? That seems to me fine pre tenure because it can be done politely and helpfully. What’s more delicate perhaps is saying that a paper isn’t interesting?

It’s honestly incredibly sad to read as someone who not only cannot attend in person conferences, but now can’t attend online ones either because they barely exist anymore

The inclusion of severe (i.e. bedbound) forms of the disease in pathophysiological research and clinical trials is not just an ethical imperative, but a scientific one